Teresa L. Young - EVP, Chief Commercial & Strategy Officer at Seres Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Commercial & Strategy Officer
Issuer Symbol
MCRB on Nasdaq
All Insider Reports
All Insider Reports

Teresa L. Young - trading volume in the past year for Seres Therapeutics, Inc.

Holdings reported by Teresa L. Young for Seres Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8,557 $72,477 $8.47 15 Feb 2026 Direct
Restricted Stock Units 780 $18,993 $0.8104 15 Feb 2026 Direct Common Stock

Transactions reported by Teresa L. Young for Seres Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.